K. Wilemon

发表

Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry.

Emily C. O'Brien, J. Knowles, D. Rader, 2014, American heart journal.

PCSK9 inhibitor access barriers—issues and recommendations: Improving the access process for patients, clinicians and payers

P. Jellinger, James A. Underberg, P. Toth, 2017, Clinical cardiology.

Developing and Optimizing Innovative Tools to Address Familial Hypercholesterolemia Underdiagnosis

Laney K. Jones, Ilene G. Ladd, Nephi A. Walton, 2021, Circulation. Genomic and precision medicine.

Clinical Genetic Testing for Familial Hypercholesterolemia: JACC Scientific Expert Panel.

D. Ledbetter, J. Knowles, D. Rader, 2018, Journal of the American College of Cardiology.

Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia: A Global Call to Action.

C. Aguilar-Salinas, G. Mensah, G. Watts, 2020, JAMA cardiology.

A proof-of-concept study of cascade screening for Familial Hypercholesterolemia in the US, adapted from the Dutch model

A. Khera, W. Weintraub, Katherine A. Wilemon, 2021, American journal of preventive cardiology.

Patient acceptance of genetic testing for familial hypercholesterolemia in the CASCADE FH Registry.

S. Gidding, Katherine A. Wilemon, A. Zhou, 2020, Journal of clinical lipidology.

Precision screening for familial hypercholesterolaemia: a machine learning study applied to electronic health encounter data.

N. Shah, J. Knowles, D. Rader, 2019, The Lancet. Digital health.

Familial hypercholesterolaemia patient support groups and advocacy: A multinational perspective.

D. Wong-Rieger, Katherine A. Wilemon, S. Williams, 2018, Atherosclerosis.

Patient experiences align with the familial hypercholesterolemia global call to action

Laney K. Jones, S. Gidding, A. Sturm, 2022, American journal of preventive cardiology.

Implementation of a Machine-Learning Algorithm in the Electronic Health Record for Targeted Screening for Familial Hypercholesterolemia

D. Rader, D. Soffer, K. Myers, 2021, Circulation. Cardiovascular quality and outcomes.

Children with Heterozygous Familial Hypercholesterolemia in the United States: Data from the CASCADE FH Registry.

Emily C. O'Brien, J. Knowles, S. Gidding, 2020, The Journal of pediatrics.

Women Living with Familial Hypercholesterolemia: Challenges and Considerations Surrounding Their Care

J. Knowles, F. Rodriguez, Katherine A. Wilemon, 2020, Current Atherosclerosis Reports.

Longitudinal low density lipoprotein cholesterol goal achievement and cardiovascular outcomes among adult patients with familial hypercholesterolemia: The CASCADE FH registry.

Emily C. O'Brien, J. Knowles, D. Rader, 2019, Atherosclerosis.

Finding missed cases of familial hypercholesterolemia in health systems using machine learning

Nigam H. Shah, Kenneth Jung, Juan M. Banda, 2019, npj Digital Medicine.

Health disparities among adult patients with a phenotypic diagnosis of familial hypercholesterolemia in the CASCADE-FH™ patient registry.

Emily C. O'Brien, J. Knowles, D. Rader, 2017, Atherosclerosis.

Access to Nonstatin Lipid-Lowering Therapies in Patients at High Risk of Atherosclerotic Cardiovascular Disease.

J. Knowles, C. Ballantyne, K. Myers, 2017, Circulation.

US physician practices for diagnosing familial hypercholesterolemia: data from the CASCADE-FH registry.

Emily C. O'Brien, J. Knowles, D. Rader, 2016, Journal of clinical lipidology.

Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry

Emily C. O'Brien, J. Knowles, D. Rader, 2016, Circulation. Cardiovascular genetics.

Reducing the burden of disease and death from familial hypercholesterolemia: a call to action.

Emily C. O'Brien, J. Knowles, M. Khoury, 2014, American heart journal.

Underutilization of cascade screening for familial hypercholesterolemia

J. Knowles, W. Neal, Katherine A. Wilemon, 2014 .

ClinVar database of global familial hypercholesterolemia‐associated DNA variants

Marina T. DiStefano, J. Knowles, S. Humphries, 2018, Human mutation.

Effect of Access to Prescribed PCSK9 Inhibitors on Cardiovascular Outcomes

D. Rader, S. Gidding, D. Staszak, 2019, Circulation. Cardiovascular quality and outcomes.

Delivery Of Cascade Screening For Hereditary Conditions: A Scoping Review Of The Literature.

D. Bowen, A. Trepanier, T. Ganiats, 2018, Health affairs.

Familial Hypercholesterolemia Causes Sudden Death.

S. Gidding, Katherine A. Wilemon, Summeet Chugh, 2019, Journal of the American College of Cardiology.

Recommendations for strengthening the role of embedded researchers to accelerate implementation in health systems: Findings from a state-of-the-art (SOTA) conference workgroup.

Sarah M. Greene, NithyaPriya S Ramalingam, A. Kilbourne, 2021, Healthcare.

COVID-19 associated risks of myocardial infarction in persons with familial hypercholesterolemia with or without ASCVD

D. Rader, D. Staszak, W. Howard, 2021, American journal of preventive cardiology.

Contemporary Homozygous Familial Hypercholesterolemia in the United States: Insights From the CASCADE FH Registry

J. Knowles, D. Rader, C. Ballantyne, 2023, Journal of the American Heart Association.

DIAGNOSIS OF FAMILIAL HYPERCHOLESTEROLEMIA: A WORK IN PROGRESS

J. Knowles, D. Rader, D. Macdougall, 2023, American Journal of Preventive Cardiology.

Abstract 12169: LDL-C Levels and Treatment Patterns Among Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry

Emily C. O'Brien, J. Knowles, D. Rader, 2015 .

Yield of Familial Hypercholesterolemia Genetic and Phenotypic Diagnoses After Electronic Health Record and Genomic Data Screening

H. Kirchner, M. Oetjens, A. Sturm, 2023, Journal of the American Heart Association.

Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry.

Emily C. O'Brien, J. Knowles, D. Rader, 2014, American heart journal.

Clinical Genetic Testing for Familial Hypercholesterolemia: JACC Scientific Expert Panel.

D. Ledbetter, J. Knowles, D. Rader, 2018, Journal of the American College of Cardiology.

Reducing the burden of disease and death from familial hypercholesterolemia: a call to action.

Emily C. O'Brien, J. Knowles, D. Rader, 2014, American heart journal.

Optimizing communication strategies and designing a comprehensive program to facilitate cascade testing for familial hypercholesterolemia

A. Sturm, A. Rahm, Emilie Simmons, 2023, BMC Health Services Research.

Abstract 19888: Improved Longitudinal Low Density Lipoprotein Cholesterol Goal Achievement Among Familial Hypercholesterolemia Patients in the CASCADE FH Patient Registry

Emily C. O'Brien, J. Knowles, D. Rader, 2017 .

Diagnosing Familial Hypercholesterolemia (FH) in the United States: Results from the CASCADE FH Patient Registry*†

Emily C. O'Brien, J. Knowles, D. Rader, 2015 .

INITIAL RESULTS FROM THE CASCADE-FH REGISTRY: CASCADE SCREENING FOR AWARENESS AND DETECTION OF FAMILIAL HYPERCHOLESTEROLEMIA

Emily C. O'Brien, J. Knowles, D. Rader, 2015 .